Funnelfeedr Logo

Sox Therapeutics AB

Sverige559526-5900Active

Developing targeted AAV gene therapies for malignant brain tumors.

Biotechnology Companysoxtherapeutics.se

Oversikt

1
Ansatte
0 SEK
Omsetning
2025
Grunnlagt

Nøkkelbeslutningstakere

christina herder

Board Member, Business Advisor

Mateo Santurio

Board Member, Business Advisor

FREDRIK Swartling

Chief Executive Officer, Founder, Board Member

tobias bergström

Clinical Study Lead, Clinical Study Coordinator

+4 flere kontakter i Funnelfeedr

Beskrivelse

Sox Therapeutics is an emerging biotechnology company founded in 2025 with the primary mission of improving cancer treatment outcomes. They specialize in developing highly innovative, targeted gene therapies specifically designed for patients suffering from malignant brain tumors. Their core technol...

Tagger

B2BBlue CollarHealthcareManufacturingPharmaceuticals

Nøkkelord

AAVBiotechnologyBrain CancerDrug DevelopmentGene TherapyOncology

Bedriftsinformasjon

Bransje
Tillverkning av läkemedel
Juridisk form
Aktiebolag
MVA-nummer
SE559526590001

Beslutningstakere

8 kontakter i Funnelfeedr

christina herder

Board Member, Business Advisor

Mateo Santurio

Board Member, Business Advisor

FREDRIK Swartling

Chief Executive Officer, Founder, Board Member

tobias bergström

Clinical Study Lead, Clinical Study Coordinator

Andre kontakter

Annika ericsson

AAV Gene Therapy Expert, CMC Drug Development

Tina LIN

Scientific Researcher, Viral Vector Design

Mats hellström

Medical Advisor, Adult Brain Tumor Treatment and Immunotherapies

sonja hutter

Co-Inventor, Scientific Advisor, Molecular Genetics and Diagnostics

Lignende bedrifter

20 lignende bedrifter i Funnelfeedr

Utforsk mer

Spørsmål om Sox Therapeutics AB

Vil du se Funnelfeedr i aksjon?

Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.

Book en demo